| No | Primary DI | Version or Model | Catalog Number | Device Description | Product Code | Product Code Name | Device Class | Brand Name |
|---|---|---|---|---|---|---|---|---|
| 1 | ECUR449100 | 100x25x4mm | 1 x 10 cc | Device Name: Matriform StripIndication for Use:Matriform® Si Strip is intended t Device Name: Matriform StripIndication for Use:Matriform® Si Strip is intended to fill bony voids or gaps of the skeletal system (posterolateral spine). These osseous defects may be surgically created or from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. In the posterolateral spine Matriform® Si Strip is to be mixed with autograft bone. The device resorbs and is replaced with bone during the healing process | MQV | Filler, Bone Void, Calcium Compound | 2 | Matriform SI-Strip |
| 2 | ECUR449050 | 50x25x4 mm | 1 x 5 cc | Device Name: Matriform SI-StripIndication for Use:Matriform® Si Strip is intende Device Name: Matriform SI-StripIndication for Use:Matriform® Si Strip is intended to fill bony voids or gaps of the skeletal system (posterolateral spine). These osseous defects may be surgically created or from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. In the posterolateral spine Matriform® Si Strip is to be mixed with autograft bone. The device resorbs and is replaced with bone during the healing process | MQV | Filler, Bone Void, Calcium Compound | 2 | Matriform SI-Strip |
| 3 | ECURH20M1000 | 1000-2000µm | 1 x 2.0 cc | Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for t Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for the filling and reconstruction of multi-walled bone defects, e.g.:- Defects after removal of bone cysts- Augmentation of the atrophied alveolar ridge- Sinus lift and sinus floor elevation (subantral augmentation)- Filling of alveolar defects following tooth extraction for alveolar ridge preservation- Filling of extraction defects to create an implant bed- Filling of two- or multi-walled infrabony pockets, and bi- and trifurcation defects- Support function for a membrane in controlled tissue regeneration (CTR)- Defects after surgical removal of retained teeth or corrective osteotomies- Other multi-walled bone defects of the alveolar processes | LYC | Bone Grafting Material, Synthetic | 2 | Osbone Dental |
| 4 | ECURH20V0250 | 250-1000µm | 1 x 2.0 cc | Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for t Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for the filling and reconstruction of multi-walled bone defects, e.g.:- Defects after removal of bone cysts- Augmentation of the atrophied alveolar ridge- Sinus lift and sinus floor elevation (subantral augmentation)- Filling of alveolar defects following tooth extraction for alveolar ridge preservation- Filling of extraction defects to create an implant bed- Filling of two- or multi-walled infrabony pockets, and bi- and trifurcation defects- Support function for a membrane in controlled tissue regeneration (CTR)- Defects after surgical removal of retained teeth or corrective osteotomies- Other multi-walled bone defects of the alveolar processes | LYC | Bone Grafting Material, Synthetic | 2 | Osbone Dental |
| 5 | ECURH10V1000 | 1000-2000µm | 1 x 1.0 cc | Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for t Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for the filling and reconstruction of multi-walled bone defects, e.g.:- Defects after removal of bone cysts- Augmentation of the atrophied alveolar ridge- Sinus lift and sinus floor elevation (subantral augmentation)- Filling of alveolar defects following tooth extraction for alveolar ridge preservation- Filling of extraction defects to create an implant bed- Filling of two- or multi-walled infrabony pockets, and bi- and trifurcation defects- Support function for a membrane in controlled tissue regeneration (CTR)- Defects after surgical removal of retained teeth or corrective osteotomies- Other multi-walled bone defects of the alveolar processes | LYC | Bone Grafting Material, Synthetic | 2 | Osbone Dental |
| 6 | ECURH10V0250 | 250-1000µm | 1 x 1.0 cc | Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for t Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for the filling and reconstruction of multi-walled bone defects, e.g.:- Defects after removal of bone cysts- Augmentation of the atrophied alveolar ridge- Sinus lift and sinus floor elevation (subantral augmentation)- Filling of alveolar defects following tooth extraction for alveolar ridge preservation- Filling of extraction defects to create an implant bed- Filling of two- or multi-walled infrabony pockets, and bi- and trifurcation defects- Support function for a membrane in controlled tissue regeneration (CTR)- Defects after surgical removal of retained teeth or corrective osteotomies- Other multi-walled bone defects of the alveolar processes | LYC | Bone Grafting Material, Synthetic | 2 | Osbone Dental |
| 7 | ECURH10M1000 | 1000-2000µm | 5 x 1.0 cc | Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for t Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for the filling and reconstruction of multi-walled bone defects, e.g.:- Defects after removal of bone cysts- Augmentation of the atrophied alveolar ridge- Sinus lift and sinus floor elevation (subantral augmentation)- Filling of alveolar defects following tooth extraction for alveolar ridge preservation- Filling of extraction defects to create an implant bed- Filling of two- or multi-walled infrabony pockets, and bi- and trifurcation defects- Support function for a membrane in controlled tissue regeneration (CTR)- Defects after surgical removal of retained teeth or corrective osteotomies- Other multi-walled bone defects of the alveolar processes | LYC | Bone Grafting Material, Synthetic | Osbone Dental | |
| 8 | ECURH10M0250 | 250-1000µm | 5 x 1.0 cc | Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for t Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for the filling and reconstruction of multi-walled bone defects, e.g.:- Defects after removal of bone cysts- Augmentation of the atrophied alveolar ridge- Sinus lift and sinus floor elevation (subantral augmentation)- Filling of alveolar defects following tooth extraction for alveolar ridge preservation- Filling of extraction defects to create an implant bed- Filling of two- or multi-walled infrabony pockets, and bi- and trifurcation defects- Support function for a membrane in controlled tissue regeneration (CTR)- Defects after surgical removal of retained teeth or corrective osteotomies- Other multi-walled bone defects of the alveolar processes | LYC | Bone Grafting Material, Synthetic | Osbone Dental | |
| 9 | ECURH05V1000 | 1000-2000µm | 1 x 0.5 cc | Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for t Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for the filling and reconstruction of multi-walled bone defects, e.g.:- Defects after removal of bone cysts- Augmentation of the atrophied alveolar ridge- Sinus lift and sinus floor elevation (subantral augmentation)- Filling of alveolar defects following tooth extraction for alveolar ridge preservation- Filling of extraction defects to create an implant bed- Filling of two- or multi-walled infrabony pockets, and bi- and trifurcation defects- Support function for a membrane in controlled tissue regeneration (CTR)- Defects after surgical removal of retained teeth or corrective osteotomies- Other multi-walled bone defects of the alveolar processes | LYC | Bone Grafting Material, Synthetic | 2 | Osbone Dental |
| 10 | ECURH05V0250 | 250-1000µm | 1 x 0.5 cc | Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for the filling and reconstruction of multi-walled bone defects, e.g.:- Defects after removal of bone cysts- Augmentation of the atrophied alveolar ridge- Sinus lift and sinus floor elevation (subantral augmentation)- Filling of alveolar defects following tooth extraction for alveolar ridge preservation- Filling of extraction defects to create an implant bed- Filling of two- or multi-walled infrabony pockets, and bi- and trifurcation defects- Support function for a membrane in controlled tissue regeneration (CTR)- Defects after surgical removal of retained teeth or corrective osteotomies- Other multi-walled bone defects of the alveolar processes | LYC | Bone Grafting Material, Synthetic | 2 | Osbone Dental |
| 11 | ECURH05M1000 | 1000-2000µm | 5 x 0.5 cc | Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for t Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for the filling and reconstruction of multi-walled bone defects, e.g.:- Defects after removal of bone cysts- Augmentation of the atrophied alveolar ridge- Sinus lift and sinus floor elevation (subantral augmentation)- Filling of alveolar defects following tooth extraction for alveolar ridge preservation- Filling of extraction defects to create an implant bed- Filling of two- or multi-walled infrabony pockets, and bi- and trifurcation defects- Support function for a membrane in controlled tissue regeneration (CTR)- Defects after surgical removal of retained teeth or corrective osteotomies- Other multi-walled bone defects of the alveolar processes | LYC | Bone Grafting Material, Synthetic | Osbone Dental | |
| 12 | ECURH05M0250 | 250-1000µm | 5 x 0.5 cc | Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for Device Name: OSBONE® DENTALlndications for Use:OSBONE® DENTAL is intended for the filling and reconstruction of multi-walled bone defects, e.g.:- Defects after removal of bone cysts- Augmentation of the atrophied alveolar ridge- Sinus lift and sinus floor elevation (subantral augmentation)- Filling of alveolar defects following tooth extraction for alveolar ridge preservation- Filling of extraction defects to create an implant bed- Filling of two- or multi-walled infrabony pockets, and bi- and trifurcation defects- Support function for a membrane in controlled tissue regeneration (CTR)- Defects after surgical removal of retained teeth or corrective osteotomies- Other multi-walled bone defects of the alveolar processes | LYC | Bone Grafting Material, Synthetic | Osbone Dental | |
| 13 | ECUR409050 | 25x50x4 mm | 1 x 5 cc | Device Name: Matriform LargeMofidication: Mouldable FoamIndication for Use:Matri Device Name: Matriform LargeMofidication: Mouldable FoamIndication for Use:Matriform Large is an implant intended to fill bony voids or gaps of the skeletal system (i.e., extremities and pelvis). These osseous defects are surgically created or the result of traumatic injury to the bone and are not intrinsic to the stability of the bony structure. Matriform Large resorbs and is replaced with bone during healing process. | MQV | Filler, Bone Void, Calcium Compound | 2 | Matriform Large |
| 14 | ECURS20M1000 | 1000-2000µm | 5 x 2.0 cc | Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recomm Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recommended for:- Augmentation or reconstructive treatment of the alveolar ridge- Filling of infrabony periodontal defects- Filling of defects after root resection, apicoectomy and cystectomy- Filling of extraction sockets to enhance preservation of the alveolar ridge- Elevation of the maxillary sinus floor- Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR)- Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR) | LYC | Bone Grafting Material, Synthetic | Cerasorb M Dental | |
| 15 | ECURS20M0500 | 500-1000µm | 5 x 2.0 cc | Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recomm Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recommended for:- Augmentation or reconstructive treatment of the alveolar ridge- Filling of infrabony periodontal defects- Filling of defects after root resection, apicoectomy and cystectomy- Filling of extraction sockets to enhance preservation of the alveolar ridge- Elevation of the maxillary sinus floor- Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR)- Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR) | LYC | Bone Grafting Material, Synthetic | Cerasorb M Dental | |
| 16 | ECURS20M0150 | 150-500µm | 5 x 2.0 cc | Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recomm Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recommended for:- Augmentation or reconstructive treatment of the alveolar ridge- Filling of infrabony periodontal defects- Filling of defects after root resection, apicoectomy and cystectomy- Filling of extraction sockets to enhance preservation of the alveolar ridge- Elevation of the maxillary sinus floor- Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR)- Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR) | LYC | Bone Grafting Material, Synthetic | Cerasorb M Dental | |
| 17 | ECURS10V0500 | 500-1000µm | 1 x 1.0 cc | Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recomm Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recommended for:- Augmentation or reconstructive treatment of the alveolar ridge- Filling of infrabony periodontal defects- Filling of defects after root resection, apicoectomy and cystectomy- Filling of extraction sockets to enhance preservation of the alveolar ridge- Elevation of the maxillary sinus floor- Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR)- Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR) | LYC | Bone Grafting Material, Synthetic | 2 | Cerasorb M Dental |
| 18 | ECURS10M1000 | 1000-2000µm | 5 x 1.0 cc | Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recomm Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recommended for:- Augmentation or reconstructive treatment of the alveolar ridge- Filling of infrabony periodontal defects- Filling of defects after root resection, apicoectomy and cystectomy- Filling of extraction sockets to enhance preservation of the alveolar ridge- Elevation of the maxillary sinus floor- Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR)- Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR) | LYC | Bone Grafting Material, Synthetic | Cerasorb M Dental | |
| 19 | ECURS10M0500 | 500-1000µm | 5 x 1.0 cc | Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recomm Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recommended for:- Augmentation or reconstructive treatment of the alveolar ridge- Filling of infrabony periodontal defects- Filling of defects after root resection, apicoectomy and cystectomy- Filling of extraction sockets to enhance preservation of the alveolar ridge- Elevation of the maxillary sinus floor- Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR)- Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR) | LYC | Bone Grafting Material, Synthetic | Cerasorb M Dental | |
| 20 | ECURS10M0150 | 150-500µm | 5 x 1.0 cc | Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recomm Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recommended for:- Augmentation or reconstructive treatment of the alveolar ridge- Filling of infrabony periodontal defects- Filling of defects after root resection, apicoectomy and cystectomy- Filling of extraction sockets to enhance preservation of the alveolar ridge- Elevation of the maxillary sinus floor- Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR)- Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR) | LYC | Bone Grafting Material, Synthetic | Cerasorb M Dental | |
| 21 | ECURS05V0500 | 500-1000µm | 1 x 0.5 cc | Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recomm Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recommended for:- Augmentation or reconstructive treatment of the alveolar ridge- Filling of infrabony periodontal defects- Filling of defects after root resection, apicoectomy and cystectomy- Filling of extraction sockets to enhance preservation of the alveolar ridge- Elevation of the maxillary sinus floor- Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR)- Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR) | LYC | Bone Grafting Material, Synthetic | 2 | Cerasorb M Dental |
| 22 | ECURS05M1000 | 1000-2000µm | 5 x 0.5 cc | Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recomm Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recommended for:- Augmentation or reconstructive treatment of the alveolar ridge- Filling of infrabony periodontal defects- Filling of defects after root resection, apicoectomy and cystectomy- Filling of extraction sockets to enhance preservation of the alveolar ridge- Elevation of the maxillary sinus floor- Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR)- Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR) | LYC | Bone Grafting Material, Synthetic | Cerasorb M Dental | |
| 23 | ECURS05M0500 | 500-1000µm | 5 x 0.5 cc | Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recomm Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recommended for:- Augmentation or reconstructive treatment of the alveolar ridge- Filling of infrabony periodontal defects- Filling of defects after root resection, apicoectomy and cystectomy- Filling of extraction sockets to enhance preservation of the alveolar ridge- Elevation of the maxillary sinus floor- Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR)- Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR) | LYC | Bone Grafting Material, Synthetic | Cerasorb M Dental | |
| 24 | ECURS05M0150 | 150-500µm | 5 x 0.5 cc | Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recomm Device Name: CERASORB® M DENTALlndications for Use:CERASORB® M DENTAL is recommended for:- Augmentation or reconstructive treatment of the alveolar ridge- Filling of infrabony periodontal defects- Filling of defects after root resection, apicoectomy and cystectomy- Filling of extraction sockets to enhance preservation of the alveolar ridge- Elevation of the maxillary sinus floor- Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR)- Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR) | LYC | Bone Grafting Material, Synthetic | Cerasorb M Dental | |
| 25 | ECURCOF2550 | 25x50x4 mm | 1 x 0.5 cc | Device Name: CERASORB® Ortho FoamMofidication: Flexible Foam StripeIndication fo Device Name: CERASORB® Ortho FoamMofidication: Flexible Foam StripeIndication for Use:Cerasorb® ORTHO Foam is an implant intended to fill bony voids or gaps of the skeletal system (i.e., extremities and pelvis). These osseous defects are surgically created or the result of traumatic injury to the bone and are not intrinsic to the stability of the bony structure. Cerasorb® Ortho Foam resorbs and is replaced with bone during healing process. | MQV | Filler, Bone Void, Calcium Compound | 2 | CERASORB® Ortho Foam |
| 26 | ECURCOF25100 | 25x100x4 mm | 1 x 10.0 cc | Device Name: CERASORB® Ortho FoamMofidication: Flexible Foam StripeIndication fo Device Name: CERASORB® Ortho FoamMofidication: Flexible Foam StripeIndication for Use:Cerasorb® ORTHO Foam is an implant intended to fill bony voids or gaps of the skeletal system (i.e., extremities and pelvis). These osseous defects are surgically created or the result of traumatic injury to the bone and are not intrinsic to the stability of the bony structure. Cerasorb® Ortho Foam resorbs and is replaced with bone during healing process. | MQV | Filler, Bone Void, Calcium Compound | 2 | CERASORB® Ortho Foam |
| 27 | ECURCOM2550 | 25x50x4 mm | 1 x 5.0 cc | Device Name: CERASORB® Ortho FoamMofidication: Mouldable FoamIndication for Use: Device Name: CERASORB® Ortho FoamMofidication: Mouldable FoamIndication for Use:Cerasorb® ORTHO Foam is an implant intended to fill bony voids or gaps of the skeletal system (i.e., extremities and pelvis). These osseous defects are surgically created or the result of traumatic injury to the bone and are not intrinsic to the stability of the bony structure. Cerasorb® Ortho Foam resorbs and is replaced with bone during healing process. | MQV | Filler, Bone Void, Calcium Compound | 2 | CERASORB® Ortho Foam |
| 28 | ECURCOM2525 | 25x25x2 mm | 1 x 2.5 cc | Device Name: CERASORB® Ortho FoamMofidication: Mouldable FoamIndication for Use: Device Name: CERASORB® Ortho FoamMofidication: Mouldable FoamIndication for Use:Cerasorb® ORTHO Foam is an implant intended to fill bony voids or gaps of the skeletal system (i.e., extremities and pelvis). These osseous defects are surgically created or the result of traumatic injury to the bone and are not intrinsic to the stability of the bony structure. Cerasorb® Ortho Foam resorbs and is replaced with bone during healing process. | MQV | Filler, Bone Void, Calcium Compound | 2 | CERASORB® Ortho Foam |
| 29 | ECURCOM2512 | 25x12x4 mm | 1 x 1.2 cc | Device Name: CERASORB® Ortho FoamMofidication: Mouldable FoamIndication for Use: Device Name: CERASORB® Ortho FoamMofidication: Mouldable FoamIndication for Use:Cerasorb® ORTHO Foam is an implant intended to fill bony voids or gaps of the skeletal system (i.e., extremities and pelvis). These osseous defects are surgically created or the result of traumatic injury to the bone and are not intrinsic to the stability of the bony structure. Cerasorb® Ortho Foam resorbs and is replaced with bone during healing process. | MQV | Filler, Bone Void, Calcium Compound | 2 | CERASORB® Ortho Foam |
| 30 | ECURCOM25100 | 25x100x4 mm | 1 x 10.0cc | Device Name: CERASORB® Ortho FoamMofidication: Mouldable FoamIndication for Use: Device Name: CERASORB® Ortho FoamMofidication: Mouldable FoamIndication for Use:Cerasorb® ORTHO Foam is an implant intended to fill bony voids or gaps of the skeletal system (i.e., extremities and pelvis). These osseous defects are surgically created or the result of traumatic injury to the bone and are not intrinsic to the stability of the bony structure. Cerasorb® Ortho Foam resorbs and is replaced with bone during healing process. | MQV | Filler, Bone Void, Calcium Compound | 2 | CERASORB® Ortho Foam |
| 31 | ECURCOF6565 | 65x65x6 mm | 1 x 25.0 cc | Device Name: CERASORB® Ortho FoamMofidication: Flexible Foam StripeIndication fo Device Name: CERASORB® Ortho FoamMofidication: Flexible Foam StripeIndication for Use:Cerasorb® ORTHO Foam is an implant intended to fill bony voids or gaps of the skeletal system (i.e., extremities and pelvis). These osseous defects are surgically created or the result of traumatic injury to the bone and are not intrinsic to the stability of the bony structure. Cerasorb® Ortho Foam resorbs and is replaced with bone during healing process. | MQV | Filler, Bone Void, Calcium Compound | 2 | CERASORB® Ortho Foam |
| 32 | 42604764313268 | 1-2mm | 1x2cc | Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistr Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistry, implantology, periodontology• Defects after removal of bone cysts• Augmentation of the atrophied alveolar ridge• Sinus floor elevation (subantral augmentation)• Filling of alveolar defects following tooth extraction for alveolar ridge preservation• Filling of extraction defects to create an implant bed• Filling of two or multi-walled infrabony pockets, and bi and trifurcation defects• Support function for a membrane in guided tissue regeneration (GTR)• Defects after surgical removal of retained teeth or corrective osteotomies• Other multi-walled bone defects of the alveolar ridge | LYC | Bone Grafting Material, Synthetic | 2 | IngeniOS HA |
| 33 | 42604764313190 | 1-2mm | 1x1cc | Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistr Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistry, implantology, periodontology• Defects after removal of bone cysts• Augmentation of the atrophied alveolar ridge• Sinus floor elevation (subantral augmentation)• Filling of alveolar defects following tooth extraction for alveolar ridge preservation• Filling of extraction defects to create an implant bed• Filling of two or multi-walled infrabony pockets, and bi and trifurcation defects• Support function for a membrane in guided tissue regeneration (GTR)• Defects after surgical removal of retained teeth or corrective osteotomies• Other multi-walled bone defects of the alveolar ridge | LYC | Bone Grafting Material, Synthetic | 2 | IngeniOS HA |
| 34 | 42604764313022 | 1-2mm | 1x0.5cc | Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistr Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistry, implantology, periodontology• Defects after removal of bone cysts• Augmentation of the atrophied alveolar ridge• Sinus floor elevation (subantral augmentation)• Filling of alveolar defects following tooth extraction for alveolar ridge preservation• Filling of extraction defects to create an implant bed• Filling of two or multi-walled infrabony pockets, and bi and trifurcation defects• Support function for a membrane in guided tissue regeneration (GTR)• Defects after surgical removal of retained teeth or corrective osteotomies• Other multi-walled bone defects of the alveolar ridge | LYC | Bone Grafting Material, Synthetic | 2 | IngeniOS HA |
| 35 | 42604764312346 | 0.25-1mm | 1x2cc | Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistr Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistry, implantology, periodontology• Defects after removal of bone cysts• Augmentation of the atrophied alveolar ridge• Sinus floor elevation (subantral augmentation)• Filling of alveolar defects following tooth extraction for alveolar ridge preservation• Filling of extraction defects to create an implant bed• Filling of two or multi-walled infrabony pockets, and bi and trifurcation defects• Support function for a membrane in guided tissue regeneration (GTR)• Defects after surgical removal of retained teeth or corrective osteotomies• Other multi-walled bone defects of the alveolar ridge | LYC | Bone Grafting Material, Synthetic | 2 | IngeniOS HA |
| 36 | 42604764312278 | 0.25-1mm | 1x1cc | Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistr Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistry, implantology, periodontology• Defects after removal of bone cysts• Augmentation of the atrophied alveolar ridge• Sinus floor elevation (subantral augmentation)• Filling of alveolar defects following tooth extraction for alveolar ridge preservation• Filling of extraction defects to create an implant bed• Filling of two or multi-walled infrabony pockets, and bi and trifurcation defects• Support function for a membrane in guided tissue regeneration (GTR)• Defects after surgical removal of retained teeth or corrective osteotomies• Other multi-walled bone defects of the alveolar ridge | LYC | Bone Grafting Material, Synthetic | 2 | IngeniOS HA |
| 37 | 42604764312100 | 0.25-1mm | 1x0.5cc | Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistr Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistry, implantology, periodontology• Defects after removal of bone cysts• Augmentation of the atrophied alveolar ridge• Sinus floor elevation (subantral augmentation)• Filling of alveolar defects following tooth extraction for alveolar ridge preservation• Filling of extraction defects to create an implant bed• Filling of two or multi-walled infrabony pockets, and bi and trifurcation defects• Support function for a membrane in guided tissue regeneration (GTR)• Defects after surgical removal of retained teeth or corrective osteotomies• Other multi-walled bone defects of the alveolar ridge | LYC | Bone Grafting Material, Synthetic | 2 | IngeniOS HA |
| 38 | 42604764312032 | 0.25-1mm | 1x0.25cc | Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistr Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistry, implantology, periodontology• Defects after removal of bone cysts• Augmentation of the atrophied alveolar ridge• Sinus floor elevation (subantral augmentation)• Filling of alveolar defects following tooth extraction for alveolar ridge preservation• Filling of extraction defects to create an implant bed• Filling of two or multi-walled infrabony pockets, and bi and trifurcation defects• Support function for a membrane in guided tissue regeneration (GTR)• Defects after surgical removal of retained teeth or corrective osteotomies• Other multi-walled bone defects of the alveolar ridge | LYC | Bone Grafting Material, Synthetic | 2 | IngeniOS HA |
| 39 | 42604764311288 | 1-2mm | 1x2cc | Device Name: IngeniOS ß-TCP Bioactiv Synthetic Bone ParticlesIndications for Use Device Name: IngeniOS ß-TCP Bioactiv Synthetic Bone ParticlesIndications for Use:Oral and maxillofacial surgery and dentistry• Augmentation or reconstructive treatment of the alveolar ridge• Filling of infrabony periodontal defects• Filling of defects after root resection, apicoectomy, and cystectomy• Filing of extraction sockets to enhance preservation of the alveolar ridge• Elevation of the maxillary sinus floor | LPK | Bone Grafting Material, For Dental Bone Repair | 2 | IngeniOS ß-TCP Bioactiv Synthetic Bone Particles |
| 40 | 42604764311110 | 1-2mm | 1x1cc | Device Name: IngeniOS ß-TCP Bioactiv Synthetic Bone ParticlesIndications for Use Device Name: IngeniOS ß-TCP Bioactiv Synthetic Bone ParticlesIndications for Use:Oral and maxillofacial surgery and dentistry• Augmentation or reconstructive treatment of the alveolar ridge• Filling of infrabony periodontal defects• Filling of defects after root resection, apicoectomy, and cystectomy• Filing of extraction sockets to enhance preservation of the alveolar ridge• Elevation of the maxillary sinus floor | LPK | Bone Grafting Material, For Dental Bone Repair | 2 | IngeniOS ß-TCP Bioactiv Synthetic Bone Particles |
| 41 | 42604764311042 | 1-2mm | 1x0.5cc | Device Name: IngeniOS ß-TCP Bioactiv Synthetic Bone ParticlesIndications for Use Device Name: IngeniOS ß-TCP Bioactiv Synthetic Bone ParticlesIndications for Use:Oral and maxillofacial surgery and dentistry• Augmentation or reconstructive treatment of the alveolar ridge• Filling of infrabony periodontal defects• Filling of defects after root resection, apicoectomy, and cystectomy• Filing of extraction sockets to enhance preservation of the alveolar ridge• Elevation of the maxillary sinus floor | LPK | Bone Grafting Material, For Dental Bone Repair | 2 | IngeniOS ß-TCP Bioactiv Synthetic Bone Particles |
| 42 | 42604764310366 | 0.25-1mm | 1x2cc | Device Name: IngeniOS ß-TCP Bioactiv Synthetic Bone ParticlesIndications for Use Device Name: IngeniOS ß-TCP Bioactiv Synthetic Bone ParticlesIndications for Use:Oral and maxillofacial surgery and dentistry• Augmentation or reconstructive treatment of the alveolar ridge• Filling of infrabony periodontal defects• Filling of defects after root resection, apicoectomy, and cystectomy• Filing of extraction sockets to enhance preservation of the alveolar ridge• Elevation of the maxillary sinus floor | LPK | Bone Grafting Material, For Dental Bone Repair | 2 | IngeniOS ß-TCP Bioactiv Synthetic Bone Particles |
| 43 | 42604764310298 | 0.25-1mm | 1x1cc | Device Name: IngeniOS ß-TCP Bioactiv Synthetic Bone ParticlesIndications for Use Device Name: IngeniOS ß-TCP Bioactiv Synthetic Bone ParticlesIndications for Use:Oral and maxillofacial surgery and dentistry• Augmentation or reconstructive treatment of the alveolar ridge• Filling of infrabony periodontal defects• Filling of defects after root resection, apicoectomy, and cystectomy• Filing of extraction sockets to enhance preservation of the alveolar ridge• Elevation of the maxillary sinus floor | LPK | Bone Grafting Material, For Dental Bone Repair | 2 | IngeniOS ß-TCP Bioactiv Synthetic Bone Particles |
| 44 | 42604764310120 | 0.25-1mm | 1x0.5cc | Device Name: IngeniOS ß-TCP Bioactiv Synthetic Bone ParticlesIndications for Use Device Name: IngeniOS ß-TCP Bioactiv Synthetic Bone ParticlesIndications for Use:Oral and maxillofacial surgery and dentistry• Augmentation or reconstructive treatment of the alveolar ridge• Filling of infrabony periodontal defects• Filling of defects after root resection, apicoectomy, and cystectomy• Filing of extraction sockets to enhance preservation of the alveolar ridge• Elevation of the maxillary sinus floor | LPK | Bone Grafting Material, For Dental Bone Repair | 2 | IngeniOS ß-TCP Bioactiv Synthetic Bone Particles |
| 45 | 42604764310052 | 0.25-1mm | 1x0.25cc | Device Name: IngeniOS ß-TCP Bioactiv Synthetic Bone ParticlesIndications for Use Device Name: IngeniOS ß-TCP Bioactiv Synthetic Bone ParticlesIndications for Use:Oral and maxillofacial surgery and dentistry• Augmentation or reconstructive treatment of the alveolar ridge• Filling of infrabony periodontal defects• Filling of defects after root resection, apicoectomy, and cystectomy• Filing of extraction sockets to enhance preservation of the alveolar ridge• Elevation of the maxillary sinus floor | LPK | Bone Grafting Material, For Dental Bone Repair | 2 | IngeniOS ß-TCP Bioactiv Synthetic Bone Particles |
| 46 | 04260476431326 | 1-2mm | 1x2cc | Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistr Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistry, implantology, periodontology• Defects after removal of bone cysts• Augmentation of the atrophied alveolar ridge• Sinus floor elevation (subantral augmentation)• Filling of alveolar defects following tooth extraction for alveolar ridge preservation• Filling of extraction defects to create an implant bed• Filling of two or multi-walled infrabony pockets, and bi and trifurcation defects• Support function for a membrane in guided tissue regeneration (GTR)• Defects after surgical removal of retained teeth or corrective osteotomies• Other multi-walled bone defects of the alveolar ridge | LYC | Bone Grafting Material, Synthetic | 2 | IngeniOS HA |
| 47 | 04260476431319 | 1-2mm | 1x1cc | Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistr Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistry, implantology, periodontology• Defects after removal of bone cysts• Augmentation of the atrophied alveolar ridge• Sinus floor elevation (subantral augmentation)• Filling of alveolar defects following tooth extraction for alveolar ridge preservation• Filling of extraction defects to create an implant bed• Filling of two or multi-walled infrabony pockets, and bi and trifurcation defects• Support function for a membrane in guided tissue regeneration (GTR)• Defects after surgical removal of retained teeth or corrective osteotomies• Other multi-walled bone defects of the alveolar ridge | LYC | Bone Grafting Material, Synthetic | 2 | IngeniOS HA |
| 48 | 04260476431302 | 1-2mm | 1x0.5cc | Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistr Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistry, implantology, periodontology• Defects after removal of bone cysts• Augmentation of the atrophied alveolar ridge• Sinus floor elevation (subantral augmentation)• Filling of alveolar defects following tooth extraction for alveolar ridge preservation• Filling of extraction defects to create an implant bed• Filling of two or multi-walled infrabony pockets, and bi and trifurcation defects• Support function for a membrane in guided tissue regeneration (GTR)• Defects after surgical removal of retained teeth or corrective osteotomies• Other multi-walled bone defects of the alveolar ridge | LYC | Bone Grafting Material, Synthetic | 2 | IngeniOS HA |
| 49 | 04260476431234 | 0.25-1mm | 1x2cc | Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistr Device Name: IngeniOS HAIndications for Use:Oral-maxillofacial surgery, dentistry, implantology, periodontology• Defects after removal of bone cysts• Augmentation of the atrophied alveolar ridge• Sinus floor elevation (subantral augmentation)• Filling of alveolar defects following tooth extraction for alveolar ridge preservation• Filling of extraction defects to create an implant bed• Filling of two or multi-walled infrabony pockets, and bi and trifurcation defects• Support function for a membrane in guided tissue regeneration (GTR)• Defects after surgical removal of retained teeth or corrective osteotomies• Other multi-walled bone defects of the alveolar ridge | LYC | Bone Grafting Material, Synthetic | 2 | IngeniOS HA |
| 50 | 04260476431012 | 0.25-1mm | 1x0.5cc | Device Name: IngeniOS ß-TCP Bioactiv Synthetic Bone ParticlesIndications for Use Device Name: IngeniOS ß-TCP Bioactiv Synthetic Bone ParticlesIndications for Use:Oral and maxillofacial surgery and dentistry• Augmentation or reconstructive treatment of the alveolar ridge• Filling of infrabony periodontal defects• Filling of defects after root resection, apicoectomy, and cystectomy• Filing of extraction sockets to enhance preservation of the alveolar ridge• Elevation of the maxillary sinus floor | LPK | Bone Grafting Material, For Dental Bone Repair | 2 | IngeniOS ß-TCP Bioactiv Synthetic Bone Particles |
| No | Primary DI | Version or Model | Catalog Number | Device Description | Brand Name | Organization Name |
|---|---|---|---|---|---|---|
| 1 | 04719875722318 | BC-G29(2.0-3.0mm,30c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 2 | 04719875722301 | BC-G28(2.0-3.0mm,20c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 3 | 04719875722295 | BC-G27(2.0-3.0mm,15c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 4 | 04719875722288 | BC-G26(1.0-2.0mm,30c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 5 | 04719875722271 | BC-G25(1.0-2.0mm,20c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 6 | 04719875722264 | BC-G24(1.0-2.0mm,15c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 7 | 04719875722257 | BC-G23(0.5-1.0mm,2c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 8 | 04719875722240 | BC-G22(1.0-2.0mm,2c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 9 | 04719875722233 | BC-G21(2.0-3.0mm,2c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 10 | 04719875722226 | BC-G20(2.0-3.0mm,0.25g) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 11 | 04719875722219 | BC-G19 (1.0-2.0mm,1.5g) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 12 | 04719875722202 | BC-G18(1.0-2.0mm,1.0g) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 13 | 04719875722196 | BC-G17(1.0-2.0mm,0.5g) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 14 | 04719875722189 | BC-G16(1.0-2.0mm,0.25g) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 15 | 04719875722172 | BC-G15(0.5-1.0mm,1g) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 16 | 04719875722165 | BC-G14(0.5-1.0mm,0.5g) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 17 | 04719875722158 | BC-G13(0.5-1.0mm,0.25g) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 18 | 04719875722141 | BC-G12(0.25-0.5mm,1g) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 19 | 04719875722134 | BC-G11(0.25-0.5mm,0.5g) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 20 | 04719875722127 | BC-G10(0.25-0.5mm,0.25g) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 21 | 04719875722110 | BC-G09(0.5-1.0mm,10c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 22 | 04719875722103 | BC-G08(0.5-1.0mm,7c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 23 | 04719875722097 | BC-G07(1.0-2.0mm,10c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 24 | 04719875722080 | BC-G06(1.0-2.0mm,7c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 25 | 04719875722073 | BC-G05(2.0-3.0mm,10c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 26 | 04719875722066 | BC-G04(2.0-3.0mm,7c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 27 | 04719875722059 | BC-G03(0.5-1.0mm,5c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 28 | 04719875722042 | BC-G02(1.0-2.0mm,5c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 29 | 04719875722035 | BC-G01(2.0-3.0mm,5c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 30 | 04719875722028 | BC-B12 (5x5x10mm,30c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 31 | 04719875722011 | BC-B11 (5x5x10mm,20c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 32 | 04719875722004 | BC-B10 (5x5x20mm,30c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 33 | 04719875721991 | BC-B09 (5x5x20mm,20c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 34 | 04719875721984 | BC-B08 (5x5x20mm,10c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 35 | 04719875721977 | BC-B07(5x5x20mm,7c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 36 | 04719875721960 | BC-B06(5x5x20mm,5c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 37 | 04719875721953 | BC-B05(5x5x10mm,10c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 38 | 04719875721946 | BC-B04(5x5x10mm,7c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 39 | 04719875721939 | BC-B03(5x5x10mm,5c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 40 | 04719875721922 | BC-B02(5x5x10mm,2c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 41 | 04719875721915 | BC-B01(5x5x20mm,2c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. | |
| 42 | 04719875720147 | BC-G29(2.0-3.0mm,30c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. (CHUTUNG) | |
| 43 | 04719875720130 | BC-G28(2.0-3.0mm,20c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. (CHUTUNG) | |
| 44 | 04719875720123 | BC-G27(2.0-3.0mm,15c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. (CHUTUNG) | |
| 45 | 04719875720116 | BC-G26(1.0-2.0mm,30c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. (CHUTUNG) | |
| 46 | 04719875720109 | BC-G25(1.0-2.0mm,20c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. (CHUTUNG) | |
| 47 | 04719875720093 | BC-G24(1.0-2.0mm,15c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. (CHUTUNG) | |
| 48 | 04719875720086 | BC-G23(0.5-1.0mm,2c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. (CHUTUNG) | |
| 49 | 04719875720079 | BC-G22(1.0-2.0mm,2c.c.) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. (CHUTUNG) | |
| 50 | 04719875720055 | BC-G20(2.0-3.0mm,0.25g) | Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. | Bicera® Resorbable Bone Substitute | WILTROM CO., LTD. (CHUTUNG) |